Rankings
▼
Calendar
RMD FY 2024 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena
RMD
ResMed Inc.
$36B
FY 2024 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$4.7B
+10.9% YoY
Gross Profit
$2.7B
56.7% margin
Operating Income
$1.3B
28.2% margin
Net Income
$1.0B
21.8% margin
EPS (Diluted)
$6.92
Cash Flow
Operating Cash Flow
$1.4B
Free Cash Flow
$1.3B
Stock-Based Comp.
$80M
Balance Sheet
Total Assets
$6.9B
Total Liabilities
$2.0B
Stockholders' Equity
$4.9B
Cash & Equivalents
$238M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4.7B
$4.2B
+10.9%
Gross Profit
$2.7B
$2.4B
+12.7%
Operating Income
$1.3B
$1.1B
+16.6%
Net Income
$1.0B
$898M
+13.7%
← Q4 2023
All Quarters
Q1 2024 →